Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.
Aygun B, Lane A, Smart LR, Santos B, Tshilolo L, Williams TN, Olupot-Olupot P, Stuber SE, Tomlinson G, Latham T, Ware RE; REACH Investigators. Aygun B, et al. Among authors: olupot olupot p. Lancet Haematol. 2024 Apr 30:S2352-3026(24)00078-4. doi: 10.1016/S2352-3026(24)00078-4. Online ahead of print. Lancet Haematol. 2024. PMID: 38701812
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial.
Power-Hays A, Tomlinson GA, Tshilolo L, Santos B, Williams TN, Olupot-Olupot P, Smart LR, Aygun B, Lane A, Stuber SE, Latham T, Ware RE. Power-Hays A, et al. Among authors: olupot olupot p. Am J Hematol. 2024 Apr;99(4):625-632. doi: 10.1002/ajh.27244. Epub 2024 Feb 8. Am J Hematol. 2024. PMID: 38332651 Clinical Trial.
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo.
Onyamboko MA, Olupot-Olupot P, Were W, Namayanja C, Onyas P, Titin H, Baseke J, Muhindo R, Kayembe DK, Ndjowo PO, Basara BB, Okalebo CB, Williams TN, Uyoga S, Taya C, Bamisaiye A, Fanello C, Maitland K, Day NPJ, Taylor WRJ, Mukaka M. Onyamboko MA, et al. Among authors: olupot olupot p. BMC Med. 2023 Oct 20;21(1):397. doi: 10.1186/s12916-023-03105-0. BMC Med. 2023. PMID: 37858129 Free PMC article. Clinical Trial.
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria.
Mukaka M, Onyamboko MA, Olupot-Olupot P, Peerawaranun P, Suwannasin K, Pagornrat W, Kouhathong J, Madmanee W, Were W, Namayanja C, Onyas P, Titin H, Baseke J, Muhindo R, Kayembe DK, Ndjowo PO, Basara BB, Bongo GS, Okalebo CB, Abongo G, Uyoga S, Williams TN, Taya C, Dhorda M, Dondorp AM, Waithira N, Imwong M, Maitland K, Fanello C, Day NPJ, Tarning J, White NJ, Taylor WRJ. Mukaka M, et al. Among authors: olupot olupot p. EBioMedicine. 2023 Oct;96:104805. doi: 10.1016/j.ebiom.2023.104805. Epub 2023 Sep 25. EBioMedicine. 2023. PMID: 37757570 Free PMC article.
PARIST study protocol: a phase I/II randomised, controlled clinical trial to assess the feasibility, safety and effectiveness of paracetamol in resolving acute kidney injury in children with severe malaria.
Paasi G, Okalebo CB, Ongodia P, Namayanja C, Eregu EEI, Abongo G, Olupot M, Amorut D, Muhindo R, Okiror W, Ndila C, Olupot-Olupot P; PARIST trial study group. Paasi G, et al. Among authors: olupot olupot p. BMJ Open. 2023 Jul 31;13(7):e068260. doi: 10.1136/bmjopen-2022-068260. BMJ Open. 2023. PMID: 37524553 Free PMC article.
108 results